NDV-01

· Relmada Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NDV-01, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy [Phase 3]

See pricing